AI2 LTD has a total of 25 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are OMNIX MEDICAL LTD, VIRAMATIX SDN BHD and BIOTECON THERAPEUTICS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | China | 2 | |
#6 | Japan | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Brazil | 1 | |
#9 | Hong Kong | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Dobson Curtis | 22 |
#2 | Crutcher Keith Alan | 3 |
#3 | Curtis Dobson | 3 |
#4 | Alan Crutcher Keith | 1 |
Publication | Filing date | Title |
---|---|---|
BRPI0612103A2 | use of a polypeptide or derivative or analog thereof, and method of preventing and / or treating fungal and / or protist contamination |